ZBNA
COLL icon

Zions Bancorporation, National Association’s Collegium Pharmaceutical COLL Stock Holding History

Zions Bancorporation, National Association’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724 Sell
20
-8
-29% -$273 ﹤0.01% 1484
2026
Q1 		$926 Buy
+28
New +$1.19K ﹤0.01% 1369

Other funds holding COLL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Zions Bancorporation, National Association's COLL Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Collegium Pharmaceutical (COLL) stake by 29% in Q2 2026, selling an estimated $273 and leaving 20 shares worth $724. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Zions Bancorporation, National Association first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. The position peaked at $926 in Q1 2026. 88 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Zions Bancorporation, National Association held 20 shares of Collegium Pharmaceutical worth $724 as of Q2 2026.
  • Zions Bancorporation, National Association sold 8 Collegium Pharmaceutical shares in Q2 2026, an estimated $273.
  • Collegium Pharmaceutical made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1484 holding.
  • Zions Bancorporation, National Association first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Zions Bancorporation, National Association's Collegium Pharmaceutical position peaked at $926 in Q1 2026.
  • 88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.